Safety, Tolerability and Immunogenicity of Two Doses of Adjuvanted Monovalent Influenza Vaccine Administered to Healthy Adult and Elderly Subjects

Clinical trial NCT00841763 · COMPLETED

Trial details

NCT number: NCT00841763
Sponsor: Novartis
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Pandemic Influenza Disease

Start date: 2008-10-01
Primary completion: 2009-04-01
Enrollment: 3647

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.